Non-invasive biomarkers for monitoring portal hypertension in metabolic dysfunction-associated steatotic liver disease (MASLD)
Expert Review of Gastroenterology & Hepatology | August 14, 2025 | Volume: 19 | Issue: 9 | Pages: 1021-1032
10.1080/17474124.2025.2548526